Диметилфумарат Сандоз

Диметилфумарат Сандоз is an oral fumaric acid ester used to manage relapsing forms of multiple sclerosis. This EU-manufactured medication helps reduce disease activity and progression. Ideal for patients seeking disease-modifying therapy. A trusted option in neurological care.

Dimethyl fumarate is prescribed to treat relapsing forms of multiple sclerosis (MS), a condition affecting the central nervous system. It helps reduce the frequency of relapses and slows disease progression. Patients with active MS may benefit from its immune-modulating effects. It is not a cure but supports long-term management of symptoms.

This medication works gradually to influence immune response and reduce inflammation in the nervous system. Users often report improved stability in daily activities over time. Some may notice fewer flare-ups or slower symptom worsening. Effects vary by individual and may take weeks to become noticeable.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children and pets. Do not use if the packaging is damaged or the medication appears altered. Consult a healthcare provider before starting or stopping this medication. Regular check-ups may be recommended during use.

Avoid alcohol while taking dimethyl fumarate, as it may increase side effects. Certain medications, including strong CYP inducers or immunosuppressants, may alter its effectiveness. Always inform your doctor about all prescription, over-the-counter, and herbal products being used. Grapefruit products may interact with this medication.